School of Health Management, Harbin Medical University, Harbin, China.
Shenzhen Center, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, China.
Qual Life Res. 2024 Dec;33(12):3335-3349. doi: 10.1007/s11136-024-03776-z. Epub 2024 Sep 13.
The aim of this study is to provide Chinese utility weights for the European Organization for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions (EORTC QLU-C10D) which is a preference-based cancer-specific utility instrument derived from the EORTC QLQ-C30.
We conducted an online survey of the general population in China, with quota sampling for age and gender. Each respondent was asked to complete a discrete choice experimental survey consisting of 16 randomly selected choice sets. The conditional logit model and mixed logit model were used to analyze respondents' preferences, and the goodness of fit of the model was tested.
A total of 2003 respondents were included in the analysis. Utility decrements within dimensions were typically monotonic. Monotonic inconsistency issues in the Fatigue, Sleep, and Nausea dimensions were normalized by monotonicity correction. Physical functioning, Pain, and Role functioning were associated with the greatest utility weights, with the smallest decrements being in Bowel problems and Emotional functioning. The utility value for the worst health state was 0.083, i.e. slightly higher than being dead.
This study provides the first China-specific set of value for the QLU-C10D based on societal preferences of the Chinese adult general population. The value set can be used as a cancer-specific scoring system for economic evaluations of new oncology therapies and technologies in China.
本研究旨在为欧洲癌症研究与治疗组织生命质量核心量表 10 维度(EORTC QLU-C10D)提供中国效用权重,该量表是一种基于偏好的癌症特异性效用工具,源自 EORTC QLQ-C30。
我们在中国进行了一项基于总体人群的在线调查,采用年龄和性别配额抽样。每个受访者都被要求完成一个由 16 个随机选择的选择集组成的离散选择实验调查。使用条件逻辑回归模型和混合逻辑回归模型来分析受访者的偏好,并测试模型的拟合优度。
共有 2003 名受访者纳入分析。各维度内的效用递减通常呈单调递减趋势。通过单调一致性修正,解决了疲劳、睡眠和恶心维度中存在的非单调性不一致问题。生理功能、疼痛和角色功能与最大效用权重相关,而在肠道问题和情绪功能方面的效用值下降最小。最差健康状态的效用值为 0.083,即略高于死亡状态。
本研究基于中国成年一般人群的社会偏好,首次为 QLU-C10D 提供了一套特定于中国的效用值。该效用值集可作为中国新肿瘤治疗方法和技术经济评估的癌症特异性评分系统。